← Back to All Filings

BioNTech Director Files Intent to Sell $15.5M in Stock

Low SignificanceNovember 5, 2025 at 5:02:49 PM EST

BioNTech SE

$BNTX144CIK: 0001776985

Subscribe to track BNTX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

BioNTech Director Files Intent to Sell $15.5M in Stock

Company: BioNTech SE ($BNTX) Form: 144 | Filed: 2025-11-05 Significance: Low

Insider: Jeggle Helmut Wolfgang Title: n/a | Relationship: Director

Transaction: • Type: Proposed Sale • Shares: 150,000 • Value: $15,514,500 • Price: ~$103.43 (implied) • Owned After: Not Stated

Key Insight: A director has filed a notice of proposed sale for $15.5M in American Depositary Shares. The transaction size is negligible, representing just 0.062% of the company's shares outstanding.

Market Context: For a large-cap company with a market capitalization of over $25 billion, this sale is considered routine and is not a material event.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: BioNTech SE (BNTX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director filed a Form 144 notice for a proposed sale of $15.5 million in stock, an amount considered immaterial relative to the company's size.
  • Market Impact: The transaction is too small to have a meaningful impact on the stock price or trading volume.

Company Information

FieldValue
CompanyBioNTech SE
Ticker SymbolBNTX (Inferred)
CIK0001776985
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameJeggle Helmut Wolfgang
CIK0001982614
Title/Positionn/a
RelationshipDirector

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-05 (Approximate Sale Date)
Transaction Coden/a
Security TypeAmerican Depositary Shares
Shares Involved150,000
Price Per Share$103.43 (Implied)
Total Value$15,514,500
Shares Owned AfterNot Stated
Ownership TypeNot Stated

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$15,514,500
% of Market Cap0.062%
Shares Transacted150,000
% of Shares Outstanding0.062%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $15.5 million proposed sale is minor for a company with a market capitalization of $25.21 billion.
  • Transaction Significance: The sale represents a negligible fraction of both the market capitalization and the total shares outstanding, indicating it is not a significant event for the company or its investors.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction's value is less than 0.1% of the company's market cap, making it highly unlikely to influence investor sentiment or stock price.

Volume & Sentiment

  • Expected Volume Impact: Minimal. A 150,000 share transaction is unlikely to create a noticeable impact on the daily trading volume of a large-cap stock.
  • Sentiment Indicator: Neutral. This filing is a routine notice of a non-material sale and does not signal any significant change in insider outlook.

Additional Context

Transaction Notes

  • This Form 144 is a notice of a proposed sale and does not represent a completed transaction. The sale is intended to occur on or around November 5, 2025.
  • A remark in the filing states, "The filing of this Form 144 shall not be construed as an admission that the undersigned is an affiliate of the issuer."
Topics:#SECFiling#Form144#BioNTech#BNTX#InsiderTrading#InsiderSell#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.